Oral Contraceptive Pills Market at US$ 1 Bn in 2018 and is anticipated to expand at a CAGR of ~6% from 2019 to 2030

The global oral contraceptive pills market for the historical period 2017–2018 and forecast period 2019–2027, high incidence of unintended pregnancies, awareness programs by governments and NGOs, increase in maternal age and late pregnancies are projected to drive the global oral contraceptive pills market during the forecast period

According to the report, the global oral contraceptive pills market was valued at US$ 1 Bn in 2018 and is anticipated to expand at a CAGR of ~6% from 2019 to 2030

Get the sample copy of report@ https://qyresearchmedical.com/sample/111909

High Incidence Rate of Unintended Pregnancies and Surge in Programs by Governments and NGOs to Promote Usage of Contraceptive Pills: Key Drivers

High incidence of unintended pregnancies among women aged between 15 and 44 drives demand for contraceptives

Large percentage of these unintended pregnancies result in abortions, which entail preventable healthcare expenditure. In an attempt to curb this redundant healthcare expenditure, governments of various countries, including developed and developing nations such as the U.S., Sweden, Norway, and India, encourage women to opt for more effective modern contraceptive methods.

Governments of various countries and NGOs such as Population Services International (PSI), Marie Stopes International, and Futures Group, along with prominent market players organize family planning programs and contraception awareness programs to expand the knowledge about contraceptives and their advantages in preventing pregnancy. For instance, Marie Stopes International entered into strategic agreements with contraceptive manufacturers, such as Bayer HealthCare, to cater to the unmet contraception (pill and implant) needs of women in the emerging and underdeveloped (Africa) economies by reducing prices by around 50%.

Increase in Maternal Age and Late Pregnancies Boost Market Growth

Globally, the average age of first time mothers is increasing, especially in developed countries such as the U.S., the U.K., France, Germany, Italy, and Japan. Financial stability, rise in literacy rates, and social factors are the major factors responsible for advancing maternal age.

For instance, in the U.S., the average age of first time mothers was 26 years in 2013. It increased to 30 years in 2018. Oral contraceptive pills are largely used to manage late pregnancies among women. Japan, China, Turkey, and Iran are some of the countries in Asia experiencing rapid rise in the average age of first time mothers.

Therefore, rise in average maternal age is likely to increase demand for oral contraceptive pills globally

Side Effects and Ethical & Social Issues to Hamper Market

Contraceptive drugs involve several health risks and side effects, discouraging their use in women. Hence, women opt for natural contraceptive and permanent contraceptive methods such as sterilization, vasectomy, tubal ligation, and withdrawal. Contraceptive pills carry serious long-term and life-threatening side effects such as increased risk of breast cancer, blood clots, and stroke. This discourages the consumers from using them. Other side effects include high blood pressure, nausea, stroke, dizziness, and mood swings.

Various ethical and social issues regarding certain contraceptive methods, especially contraceptive pills, lead to restriction on their usage in some countries. For instance, sale of emergency contraceptive pills is restricted in the Middle East, as these are considered a means of abortion.

Oral Contraceptive Pills Market: Competitive Landscape

This report profiles major players in the global oral contraceptive pills market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

View full report@ https://qyresearchmedical.com/report/oral-contraceptive-pills-market-global-industry-analysis-size-share-growth-trends-and-forecast-2019-2030/111909

The global oral contraceptive pills market is highly fragmented, with the presence of a number of international as well as regional players

Leading players operating in the global oral contraceptive pills market are

  • Allergan plc
  • Bayer AG
  • Johnson & Johnson Services, Inc.
  • Mankind Pharma Ltd.
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Piramal Enterprises
  • Syzygy Healthcare LLC

Key Questions Answered in Oral Contraceptive Pills Market Report

  • What is the scope of growth of product companies in the global oral contraceptive pills market?
  • What will be the Y-o-Y growth of the global oral contraceptive pills market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global oral contraceptive pills market?
  • Will North America continue to be the most profitable market for oral contraceptive pills providers?
  • Which factors are anticipated to hamper the growth of the global oral contraceptive pills market during the forecast period?
  • Which are the leading companies in the global oral contraceptive pills market?

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111909/2900

Oral Contraceptive Pills Market – Segmentation

Type

  • Combination
  • Monophasic
  • Triphasic
  • Others
  • Progestin Only
  • Others

Category

  • Generic
  • Branded

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Oral Contraceptive Pills Market

4. Market Overview

4.1. Introduction

4.1.1. Type Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Oral Contraceptive Pills Market Analysis and Forecast, 2017–2030

4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Regulatory Scenario, by Region/Globally

5.2. Pipeline Analysis

5.3. Mergers & Acquisitions

6. Global Oral Contraceptive Pills Market Analysis and Forecast, by Type

6.1. Introduction & Definition

6.1.1. Key Findings / Developments

6.2. Global Oral Contraceptive Pills Market Value Forecast, by Type, 2017–2030

6.2.1. Combination

6.2.1.1. Monophasic

6.2.1.2. Triphasic

6.2.1.3. Others

6.2.2. Progestin Only

6.2.3. Others

6.3. Global Oral Contraceptive Pills Market Attractiveness, by Type

7. Global Oral Contraceptive Pills Market Analysis and Forecast, by Category

7.1. Introduction & Definition

7.1.1. Key Findings / Developments

7.2. Global Oral Contraceptive Pills Market Value Forecast, by Category, 2017–2030

7.2.1. Generic

7.2.2. Branded

7.3. Global Oral Contraceptive Pills Market Attractiveness, by Category

8. Global Oral Contraceptive Pills Market Analysis and Forecast, by Region

8.1. Key Findings

8.2. Global Oral Contraceptive Pills Market Value Forecast, by Region

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. North America Oral Contraceptive Pills Market Attractiveness, by Region

9. North America Oral Contraceptive Pills Market Analysis and Forecast

9.1. Introduction

9.1.1. Key Findings

9.2. North America Oral Contraceptive Pills Market Value (US$ Mn) Forecast, by Type, 2017–2030

9.2.1. Combination

9.2.1.1. Monophasic

9.2.1.2. Triphasic

9.2.1.3. Others

9.2.2. Progestin Only

9.2.3. Others

9.3. North America Oral Contraceptive Pills Market Value (US$ Mn) Forecast, by Category, 2017–2030

9.3.1. Generic

9.3.2. Branded

9.4. North America Oral Contraceptive Pills Market Value (US$ Mn) Forecast, by Country, 2017–2030

9.4.1. U.S.

9.4.2. Canada

9.5. North America Oral Contraceptive Pills Market Attractiveness Analysis

9.5.1. By Type

9.5.2. By Category

9.5.3. By Country

10. Europe Oral Contraceptive Pills Market Analysis and Forecast

…….

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111909/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi